TET1 and acute myeloid leukemia: Wang et al48 linked TET1 expression to M0/M1 morphology and nucleophosmin 1 (NPM1) mutations, correlating with worse survival rates, particularly in acute myeloid leukemia without CCAAT enhancer binding protein alpha (CEBPA) mutations.